tiprankstipranks
Trending News
More News >

Agios Pharmaceuticals appoints Capello to board of directors

Agios Pharmaceuticals (AGIO) announced that Jeffrey Capello has been appointed to its board of directors. Agios also announced that Paul Clancy will step down from the board of directors at the end of his term, effective June 13, 2023. Most recently, he was the chief financial officer for Biogen (BIIB), where he partnered with the executive team to achieve consistent and predictable financial outcomes while enhancing the R&D pipeline and implementing a disciplined capital allocation process.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on AGIO:

Disclaimer & DisclosureReport an Issue